[{"Assets_0_FY_USD":11628800000.0,"CIK":"1585364","CommonStockDividendsPerShareDeclared_4_FY_USD":0.64,"CommonStockSharesConverted_0_FY_shares":140800000.0,"Country":"United States","EarningsPerShareBasic_1_FY_USD":0.52,"EarningsPerShareBasic_4_FY_USD":0.84,"EarningsPerShareDiluted_1_FY_USD":0.52,"EarningsPerShareDiluted_4_FY_USD":0.84,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":698900000.0,"NetIncomeLossConverted_1_FY_USD":73100000.0,"NetIncomeLossConverted_4_FY_USD":119600000.0,"OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_FY_USD":1283000000.0,"RevenuesConverted_4_FY_USD":4946200000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":6170600000.0,"StockholdersEquity_0_FY_USD":6170500000.0,"Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":141200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":142600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":140800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":142300000.0,"filed":"20180301","footnote":"nan","form":"10-K","fp":"FY","fy":"2017.0","name":"PERRIGO CO PLC","period":"20171231","qtrs":"0","uom":"USD"}]